Kyverna Therapeutics
KYTX
#7728
Rank
โ‚น32.28 B
Marketcap
โ‚น737.16
Share price
0.00%
Change (1 day)
89.22%
Change (1 year)

Kyverna Therapeutics (KYTX) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : โ‚น3.79 Billion

According to Kyverna Therapeutics's latest financial reports the company's total liabilities are โ‚น3.79 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Kyverna Therapeutics - Total liabilities on balance sheet (from 2022 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น3.26 B-81.02%
2023-12-31โ‚น17.19 B47.48%
2022-12-31โ‚น11.66 B18.92%
2021-12-31โ‚น9.80 B